Pmgc (ELAB) Shares Decline by 0.71 % on Thursday 22nd
- Closing price: USD 2.78
- Trading session: 24 hours ending at 03:09 AM Central Europe, Thursday 22nd
- Market capitalization: USD 2.3 million
- Total shares outstanding: 809,200
- Volume traded in last 24 hours: USD 13,200
- Month‑end change: -36.43 %
Technical Indicators
| Indicator | Value |
|---|
| Simple moving average (200 days) | USD 47.90 |
| 52‑week high | USD 1,538.40 (23 Oct 2025) |
| 52‑week low | USD 2.58 (01 Oct 2026) |
| Company | Ticker | % Change | Current Price | Market Cap |
|---|
| Adagio Medical | ADGM | +0.83 % | USD 0.12 | USD 2.7 million |
| Nexgel | NXGL | –8.10 % | USD 5.28 | USD 2.7 million |
| Lqr House | YHC | –10.10 % | USD 1.79 | USD 2.6 million |
| Singularity Future Technology | SGLY | +2.04 % | USD 0.45 | USD 2.7 million |
| Vivosim Labs | VIVS | +6.25 % | USD 0.18 | USD 2.6 million |
Company Overview – Elevai Labs Inc.
Elevai Labs Inc., trading under the ticker ELAB, is a physician‑dispensed skincare company headquartered in Newport Beach, United States. The company focuses on modernizing aesthetic skincare through research and development of science‑driven topical products that align with the medical aesthetics sector. Elevai Labs serves a global customer base. Additional information about its product portfolio and corporate initiatives is available on the company website: www.elevaiskincare.com
. The stock was first listed on Nasdaq on November 30th, 2023.
